BioCatalystWatch
CRVSWorkspace / CRVS / OverviewCompany library
Corvus Pharmaceuticals, Inc. logo

Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. (CRVS)

Website

Price
Market cap
Next catalystCohort 2 enrollment planned to begin in late November 2026Soquelitinib — Angel Pharma China Phase 1b/2 · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Soquelitinib

ITK

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Soquelitinib

ITK

PreINDP1P2P3FilingApproved
Upcoming / outlook

Soquelitinib

ITK

PreINDP1P2P3FilingApproved
Upcoming / outlook

Soquelitinib

ITK

PreINDP1P2P3FilingApproved
Upcoming / outlook

Soquelitinib

ITK

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Soquelitinib

ITK

PreINDP1P2P3FilingApproved
Upcoming / outlook

Soquelitinib

ITK

PreINDP1P3FilingApproved
Upcoming / outlook

Soquelitinib

ITK

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Soquelitinib

ITK

PreINDP1P2P3FilingApproved
Upcoming / outlook

Soquelitinib

ITK

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

ciforadenant (CPI-444)

A2A receptor

PreINDP1P2P3FilingApproved

Partner / License out

Soquelitinib

ITK

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

History / paused

Soquelitinib

ITK

PreINDP1P2P3FilingApproved
Upcoming / outlook

CD73

PreINDP1P2P3FilingApproved
Soquelitinib

ITK

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CRVS PR & News

PR & News

CRVS SEC archive